Page 17 - Bloomberg_Businessweek

LOOK AHEAD ○ Battery maker Energizer Holdings ○ McDonald’s will release its ○ German auto giant Daimler holds
hosts its annual meeting on Jan. 29 fourth-quarter earnings report its annual investor conference in
in St. Louis Stuttgart on Feb. 2

B

U

S

I

N

E

S 15

S

○ The drugmaker is beset by Just about everything that can go wrong in the
patient lawsuits, regulatory world of pharma has gone wrong at Endo, which
makes both branded and generic drugs. Through
challenges, and looming debt a dealmaking spree largely led by its former chief
payments executive officer, the company amassed debt of
more than $8 billion—five times its market cap-
italization. That might be tolerable for a high-
growth company, but Endo faces cratering prices
Opioids. Vaginal mesh. Testosterone. These have for generic medicines even as it must deal with a
become some of the ugliest words in the pharma- slew of litigation involving its products.
ceutical industry, telegraphing medical treatments The new leadership says the Dublin, Ireland-
gone awry, in some cases leaving behind disabled based company can fix all this; it will just take
customers, epic legal battles, and vast capital time. “It’s very important to know that we’re not
destruction. Some of the industry’s largest compa- running or hiding from our challenges,” says CEO
nies have been mired in lawsuits and government Paul Campanelli. “We’re well-equipped to handle January 29, 2018
probes over these issues. But no company has these types of issues.” Edited by
been haunted by the drug industry’s worst night- That includes writing massive checks to James E. Ellis
mares as mercilessly as Endo International Plc. get beyond some of Endo’s legal woes. As of Businessweek.com